• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同作用机制的降压药物对人工起搏器患者心脏血流动力学的影响]

[Effects of antihypertensive drugs with different mechanism of action on cardiac hemodynamics in patients with artificial pacemaker].

作者信息

Iskenderov B G, Latyshev D S

出版信息

Klin Med (Mosk). 2000;78(10):37-40.

PMID:11220897
Abstract

Cardiohemodynamic effects of obsidan, nifedipin, captopril and prasosine were compared when the drugs were given in a 4-week course regarding circulation type and stimulation regime to 74 patients with artificial pacemaker suffering from mild or moderate essential hypertension. A peculiar action of obsidan, nifedipin and prasosine in cardiac pacing found at echocardiography is explained by the absence of frequency-dependent (chronotropic) cardiohemodynamic effects. Obsidan lowered blood pressure most effectively in hyperkinetic circulation. Nifedipine, captopril and prasosine were more potent in eu- and hypokinetic circulation. Reduction of arterial pressure by the above peripheral vasodilators in patients with hyperkinetic circulation results from a fall of total peripheral vascular resistance initially elevated by 16.5%, on the average. In isolated ventricular stimulation (regime VVI) vs atrial one (AAI regime) hypotensive action of the above drugs was more potent, but side effects were more frequent.

摘要

在为期4周的疗程中,针对74例患有轻度或中度原发性高血压的人工起搏器患者,比较了奥昔坦、硝苯地平、卡托普利和哌唑嗪在不同循环类型和刺激方案下的心脏血液动力学效应。在超声心动图检查中发现,奥昔坦、硝苯地平及哌唑嗪在心脏起搏方面具有独特作用,这可通过其不存在频率依赖性(变时性)心脏血液动力学效应来解释。奥昔坦在高动力循环中降压效果最为显著。硝苯地平、卡托普利和哌唑嗪在正常动力和低动力循环中效果更佳。上述外周血管扩张剂使高动力循环患者的动脉压降低,这是由于平均升高了16.5%的总外周血管阻力下降所致。在心室单腔起搏(VVI模式)与心房单腔起搏(AAI模式)相比时,上述药物的降压作用更强,但副作用更频繁。

相似文献

1
[Effects of antihypertensive drugs with different mechanism of action on cardiac hemodynamics in patients with artificial pacemaker].[不同作用机制的降压药物对人工起搏器患者心脏血流动力学的影响]
Klin Med (Mosk). 2000;78(10):37-40.
2
[The cardiohemodynamic characteristics of the action of obzidan in patients with an artificial pacemaker and ischemic heart disease with different types of blood circulation].[奥布西丹对植入人工起搏器且患有不同血液循环类型缺血性心脏病患者作用的心脏血液动力学特征]
Eksp Klin Farmakol. 1996 Jul-Aug;59(4):21-4.
3
[Non-pharmacological correction of arterial pressure in hypertensive patients with a pacemaker].
Klin Med (Mosk). 2002;80(12):23-6.
4
[The characteristics of the effect of obzidan on the cardiac hemodynamics in patients with an artificial pacemaker when used one time and over a course of treatment].[单次及疗程使用奥布西旦对人工起搏器患者心脏血流动力学的影响特征]
Ter Arkh. 1996;68(5):60-3.
5
[Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation].[观察不同类型循环的原发性高血压患者中黑曜石的作用评估] (注:原文中obsidan可能有误,暂按此翻译)
Ter Arkh. 1986;58(11):29-32.
6
[Cardio-hemodynamic effects of domestic adrenergic beta-antagonist proxodolol in hypertension in patients with pacemaker].国产肾上腺素能β受体阻滞剂心得平对起搏器植入患者高血压的心脏血液动力学影响
Klin Med (Mosk). 1999;77(4):29-31.
7
[Comparative anti-hypertensive effectiveness and tolerance of drugs in patients with mild and moderate arterial hypertension].[轻度和中度动脉高血压患者药物的比较抗高血压疗效及耐受性]
Klin Med (Mosk). 1999;77(8):33-6.
8
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
9
[Optimization of sanatorium treatment of patients with essential hypertension stage II by chronotherapy].[通过时间疗法优化疗养院对二期原发性高血压患者的治疗]
Klin Med (Mosk). 2003;81(11):46-50.
10
Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.评估地拉普利联合吲达帕胺治疗轻至中度原发性高血压的疗效和耐受性:一项随机、多中心、对照研究。
J Hum Hypertens. 2003 Feb;17(2):139-46. doi: 10.1038/sj.jhh.1001514.